CNC · Centene Corp
Market Cap
$33.12B
Shares
494.00M
CNC metrics
84 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$67.04
Market cap
$33.12B
Price action
19 metricsPrice change (1W)
+4.1%
Price change (30D)
+6.0%
Price change (3M)
+8.5%
Price change (6M)
+57.2%
Price change (YTD)
+65.3%
Price change (1Y)
+126.3%
Trailing year
Price change (5Y)
+5.7%
52-week high
$68.72
52-week low
$28.65
Change from 52-week high
-1.0%
Change from 52-week low
+137.4%
Annualized volatility
49.1%
Beta
0.4
RSI (14D)
59.6
Price vs SMA 50
+3.9%
Price vs SMA 200
+35.5%
Avg volume (3M)
4.90M
Relative volume
0.7
Average dollar volume
$316.97M
Company
3 metricsSector
Healthcare
Industry
Healthcare Plans
Shares outstanding
494.00M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 909.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 610.1%
P / book
1.5
reciprocal yield 67.8%
FCF yield
26.9%
TTM · current market cap
Buyback yield
0.1%
P / FCF
3.7
reciprocal yield 26.9%
P / operating cash flow
3.4
reciprocal yield 29.3%
Earnings yield
-15.3%
Historical valuation
8 metricsP / E historical average (3Y)
27.2×
reciprocal yield 3.7%
P / E historical average (5Y)
27.2×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 590.9%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 425.5%
EV / EBIT historical average (3Y)
16.3×
reciprocal yield 6.1%
EV / EBIT historical average (5Y)
18.4×
reciprocal yield 5.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-10-27
Last earnings
2026-07-28
Profitability
9 metricsGross margin
8.0%
Operating margin
-2.8%
Trailing 12 months
Net margin
-2.5%
Gross profit (TTM)
$16.17B
Operating profit (TTM)
−$5.64B
Net income (TTM)
−$5.10B
Trailing 12 months
Diluted EPS (TTM)
$-10.35
FCF margin
4.4%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+9.9%
Year over year
Net income growth YoY
-301.9%
Revenue (TTM)
$202.94B
Trailing 12 months
EPS growth YoY
-314.4%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+10.5%
Revenue CAGR (5Y)
+11.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-6.3%
FCF CAGR (5Y)
-1.4%
Quality
14 metricsReturn on equity
-22.6%
Return on assets
-6.1%
Debt / equity
0.7
Current ratio
1.1
EBITDA (TTM)
−$4.39B
Free cash flow (TTM)
$8.95B
Quick ratio
1.1
Interest coverage
-8.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10.95B
Latest balance sheet
Cash & equivalents
$24.15B
Total assets
$83.01B
Total debt
$16.11B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$9.75B
Capital expenditures (TTM)
$798.00M
R&D (TTM)
—
SG&A (TTM)
$13.02B
Stock compensation (TTM)
$236.00M
R&D / revenue
—
Stock compensation / revenue
0.1%
Ownership (13F)
3 metrics13F filers
1,008
13F filer change QoQ
+133
Institutional ownership
102.2%
Short interest
3 metricsShort interest
2.7%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
−$12.06M
Insider-sentiment score
23 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1071739
CUSIP
15135B101
13F (30d)
547 filings
538 filers
Visit website
Investor relations